|Articles|June 1, 1999

June 1999
Volume 5
Issue 6

Continuity of Care: Is It Cost Effective?

Author(s)Michele Raddish, MD, MPH, Susan D. Horn, PhD, Phoebe D. Sharkey, PhD

Download PDF: Continuity of Care: Is It Cost Effective?

Articles in this issue

about 27 years ago

Article

Variations in and Correlates of Length of Stay in Academic Hospitals among Patients with Heart Failure Resulting from Systolic Dysfunction

about 27 years ago

Article

Nursing Facilities and Managed Care

about 27 years ago

Article

The Role of Respiratory Care Practitioners in a Changing Healthcare System: Emerging Areas of Clinical Practice

about 27 years ago

Article

The Impact of TennCare on Patient Satisfaction with Care

about 27 years ago

Article

Continuation of Postmenopausal Hormone Replacement Therapy in a Large Health Maintenance Organization: Transdermal Matrix Patch versus Oral Estrogen Therapy

about 27 years ago

Article

Topical Corticosteroids: Considerations for Appropriate Use

about 27 years ago

Article

Variation in Length of Stay in Patients Hospitalized with Congestive Heart Failure

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

State Medicaid Budgetary Implications of New Cancers

ByAmanda C. Chen, PhD,Anuraag R. Kansal, PhD,David C. Grabowski, PhD

July 2nd 2026

Blood Pressure Control Among Adherent vs Nonadherent Medicare Patients With Hypertension

ByKaitlyn T. Haas, PharmD,Joseph J. Saseen, PharmD, BCPS, BCACP,Oliver Titus, MS,Nathan Lamberton, PharmD, BCACP,Lisa M. Schilling, MD, MSPH,Keri N. Hogan, PharmD, BCACP,Alison Marks, BA,Sarah J. Billups, PharmD, BCPS

July 1st 2026

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Continuity of Care: Is It Cost Effective?

Articles in this issue

Related Content

State Medicaid Budgetary Implications of New Cancers

Blood Pressure Control Among Adherent vs Nonadherent Medicare Patients With Hypertension

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Trending on AJMC

Tec-Dara Shows MRD-Negative, PFS Benefit in High-Risk Myeloma, But Longer Follow-Up Needed: Rahul Banerjee, MD

Early Treatment Succeeds in CRC With Next Generation KRAS Inhibitor Calderasib Plus Cetuximab Combo

Adam Kittai, MD, on Sequencing, Cost, and the Road to CLL Cure

Real-World Data Show MASH Progresses Faster Than Trials Suggest

emtelligent Turns Unstructured Clinical Data Into Actionable Insights

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Continuity of Care: Is It Cost Effective?

Articles in this issue

Related Content

State Medicaid Budgetary Implications of New Cancers

Blood Pressure Control Among Adherent vs Nonadherent Medicare Patients With Hypertension

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Trending on AJMC

Tec-Dara Shows MRD-Negative, PFS Benefit in High-Risk Myeloma, But Longer Follow-Up Needed: Rahul Banerjee, MD

Early Treatment Succeeds in CRC With Next Generation KRAS Inhibitor Calderasib Plus Cetuximab Combo

Adam Kittai, MD, on Sequencing, Cost, and the Road to CLL Cure

Real-World Data Show MASH Progresses Faster Than Trials Suggest

emtelligent Turns Unstructured Clinical Data Into Actionable Insights